Brand name products often contain multiple ingredients. To read detailed information about each ingredient, click on the link for the individual ingredient shown above.
This is a "branded ingredient." This means that it is an ingredient used in other companies' products. For example, this product might be just one ingredient used in another company's product that contains multiple ingredients. These branded ingredients usually are not available for sale as stand alone products for consumers.
Below is general information about the effectiveness of the known ingredients contained in the product Inocell. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
INSUFFICIENT RELIABLE EVIDENCE to RATE
Below is general information about the safety of the known ingredients contained in the product Inocell. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
LIKELY SAFE ...when consumed in amounts commonly found in foods (1854).
POSSIBLY SAFE ...when used orally and appropriately, short-term. IP-6 600 mg twice daily has been used with apparent safety for up to 2 weeks (102320). There is insufficient reliable information available about the safety of IP-6 when used orally in higher doses or for longer than 2 weeks or when used topically.
PREGNANCY AND LACTATION: LIKELY SAFE
when consumed in amounts commonly found in foods (1854).
There is insufficient reliable information available about the safety of IP-6 when used in amounts greater than those found in foods; avoid using.
Below is general information about the interactions of the known ingredients contained in the product Inocell. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Theoretically, concomitant use of IP-6 with drugs that affect platelet aggregation may increase the risk of bleeding. In vitro IP-6 can inhibit platelet aggregation (1867). This effect has not been demonstrated in humans.
|
Below is general information about the adverse effects of the known ingredients contained in the product Inocell. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
General ...Orally, IP-6 is well tolerated when consumed in amounts commonly found in foods (1854). No adverse effects have been reported when IP-6 is used in medicinal amounts; however, a thorough evaluation of safety outcomes has not been conducted.
